Literature DB >> 20417618

Deficiency of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1 accelerates atherogenesis in apolipoprotein E-deficient mice.

Levent M Akyürek1, Manfred Boehm, Michelle Olive, Alex-Xianghua Zhou, Hong San, Elizabeth G Nabel.   

Abstract

Cyclin-dependent kinase inhibitors, p21(Cip1) and p27(Kip1), are upregulated during vascular cell proliferation and negatively regulate growth of vascular cells. We hypothesized that absence of either p21(Cip1) or p27(Kip1) in apolipoprotein E (apoE)-deficiency may increase atherosclerotic plaque formation. Compared to apoE(-/-) aortae, both apoE(-/-)/p21(-/-) and apoE(-/-)/p27(-/-) aortae exhibited significantly more atherosclerotic plaque following a high-cholesterol regimen. This increase was particularly observed in the abdominal aortic regions. Deficiency of p27(Kip1) accelerated plaque formation significantly more than p21(-/-) in apoE(-/-) mice. This increased plaque formation was in parallel with increased intima/media area ratios. Deficiency of p21(Cip1) and p27(Kip1) accelerates atherogenesis in apoE(-/-) mice. These findings have significant implications for our understanding of the molecular basis of atherosclerosis associated with excessive proliferation of vascular cells. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20417618      PMCID: PMC2884298          DOI: 10.1016/j.bbrc.2010.04.097

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Cell cycle signaling and cardiovascular disease.

Authors:  E G Nabel; M Boehm; L M Akyurek; T Yoshimoto; M F Crook; M Olive; H San; X Qu
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2002

2.  Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice.

Authors:  G Condorelli; J K Aycock; G Frati; C Napoli
Journal:  FASEB J       Date:  2001-10       Impact factor: 5.191

3.  Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis.

Authors:  Aksam J Merched; Lawrence Chan
Journal:  Circulation       Date:  2004-12-13       Impact factor: 29.690

4.  p27-p16 Chimera: a superior antiproliferative for the prevention of neointimal hyperplasia.

Authors:  J G McArthur; H Qian; D Citron; G G Banik; L Lamphere; J Gyuris; L Tsui; S E George
Journal:  Mol Ther       Date:  2001-01       Impact factor: 11.454

5.  Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.

Authors:  F C Tanner; M Boehm; L M Akyürek; H San; Z Y Yang; J Tashiro; G J Nabel; E G Nabel
Journal:  Circulation       Date:  2000-05-02       Impact factor: 29.690

6.  p27-p16 fusion gene inhibits angioplasty-induced neointimal hyperplasia and coronary artery occlusion.

Authors:  L V Tsui; A Camrud; J Mondesire; P Carlson; N Zayek; L Camrud; B Donahue; S Bauer; A Lin; D Frey; M Rivkin; A Subramanian; R Falotico; J Gyuris; R Schwartz; J G McArthur
Journal:  Circ Res       Date:  2001-08-17       Impact factor: 17.367

7.  Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms.

Authors:  R Pyo; J K Lee; J M Shipley; J A Curci; D Mao; S J Ziporin; T L Ennis; S D Shapiro; R M Senior; R W Thompson
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

8.  The growth suppressor p27(Kip1) protects against diet-induced atherosclerosis.

Authors:  A Díez-Juan; V Andrés
Journal:  FASEB J       Date:  2001-09       Impact factor: 5.191

9.  Mouse genetic evidence that tranilast reduces smooth muscle cell hyperplasia via a p21(WAF1)-dependent pathway.

Authors:  Masataka Sata; Akihiro Takahashi; Kimie Tanaka; Miwa Washida; Nobukazu Ishizaka; Junya Ako; Masao Yoshizumi; Yasuyoshi Ouchi; Takahiro Taniguchi; Yasunobu Hirata; Mitsuhiro Yokoyama; Ryozo Nagai; Kenneth Walsh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-08-01       Impact factor: 8.311

10.  Bone marrow-derived immune cells regulate vascular disease through a p27(Kip1)-dependent mechanism.

Authors:  Manfred Boehm; Michelle Olive; Andrea L True; Martin F Crook; Hong San; Xuan Qu; Elizabeth G Nabel
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

View more
  11 in total

Review 1.  The COP9 signalosome and vascular function: intriguing possibilities?

Authors:  Douglas S Martin; Xuejun Wang
Journal:  Am J Cardiovasc Dis       Date:  2015-03-20

2.  A selective microRNA-based strategy inhibits restenosis while preserving endothelial function.

Authors:  Gaetano Santulli; Anetta Wronska; Kunihiro Uryu; Thomas G Diacovo; Melanie Gao; Steven O Marx; Jan Kitajewski; Jamie M Chilton; Kemal Marc Akat; Thomas Tuschl; Andrew R Marks; Hana Totary-Jain
Journal:  J Clin Invest       Date:  2014-08-18       Impact factor: 14.808

3.  Elevation of miR-221 and -222 in the internal mammary arteries of diabetic subjects and normalization with metformin.

Authors:  Chasity B Coleman; Daniel J Lightell; Stephanie C Moss; Michael Bates; Patrick E Parrino; T Cooper Woods
Journal:  Mol Cell Endocrinol       Date:  2013-05-03       Impact factor: 4.102

4.  Tanshinone IIA inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via Akt/Skp2/p27-associated pathway.

Authors:  Ying Luo; Dun-Quan Xu; Hai-Ying Dong; Bo Zhang; Yi Liu; Wen Niu; Ming-Qing Dong; Zhi-Chao Li
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

5.  A form of the metabolic syndrome associated with mutations in DYRK1B.

Authors:  Ali R Keramati; Mohsen Fathzadeh; Gwang-Woong Go; Rajvir Singh; Murim Choi; Saeed Faramarzi; Shrikant Mane; Mohammad Kasaei; Kazem Sarajzadeh-Fard; John Hwa; Kenneth K Kidd; Mohammad A Babaee Bigi; Reza Malekzadeh; Adallat Hosseinian; Masoud Babaei; Richard P Lifton; Arya Mani
Journal:  N Engl J Med       Date:  2014-05-15       Impact factor: 176.079

Review 6.  Human miR-221/222 in Physiological and Atherosclerotic Vascular Remodeling.

Authors:  Dmitry A Chistiakov; Igor A Sobenin; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Biomed Res Int       Date:  2015-06-29       Impact factor: 3.411

7.  Dysregulation of the Mammalian Target of Rapamycin and p27Kip1 Promotes Intimal Hyperplasia in Diabetes Mellitus.

Authors:  Thomas Cooper Woods
Journal:  Pharmaceuticals (Basel)       Date:  2013-05-27

8.  Baicalin inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via the AKT/HIF-1α/p27-associated pathway.

Authors:  Lin Zhang; Zhichen Pu; Junsong Wang; Zhifeng Zhang; Dongmei Hu; Junjie Wang
Journal:  Int J Mol Sci       Date:  2014-05-09       Impact factor: 5.923

9.  Galectin-3 inhibition ameliorates hypoxia-induced pulmonary artery hypertension.

Authors:  Mingwen Hao; Miaomiao Li; Wenjun Li
Journal:  Mol Med Rep       Date:  2016-12-09       Impact factor: 2.952

10.  Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study.

Authors:  Fahad W Ahmed; Sherin Bakhashab; Inda T Bastaman; Rachel E Crossland; Michael Glanville; Jolanta U Weaver
Journal:  Int J Mol Sci       Date:  2018-10-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.